Conclusions FOB legislation: Best chance for defined exclusivity periods with greater certainty, reduced litigation – All biopharmaceutical companies need to get out of the Certification/Litigation cycle – Imperative to work towards consensus on fixed period of 10 - 12 years of exclusivity, equal to effective patent term for pharmaceuticals
{}